{"id":"W2658794391","doi":"10.14740/jh320w","title":"Rituximab-Based Therapy in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: Individualized Risk-Adapted Therapy Approach Using Molecular Subtypes","year":2017,"lang":"en","type":"review","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lenalidomide; Diffuse large B-cell lymphoma; Rituximab; Oncology; Internal medicine; Ibrutinib; Vincristine; Lymphoma; Bortezomib; CHOP; BCL6; Cyclophosphamide; Immunology; Chronic lymphocytic leukemia; B cell; Germinal center; Multiple myeloma; Leukemia; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009006922,0.0008848137,0.006024296,0.001016928,0.0001688358,0.00008112619,0.0005896137,0.000857825,0.00004455577],"category_scores_gemma":[0.0003853734,0.0005776188,0.001590457,0.0003009842,0.0001305094,0.0001317691,0.00007064747,0.0005598574,0.00001622433],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005307326,"about_ca_system_score_gemma":0.001522211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001079026,"about_ca_topic_score_gemma":0.00000815824,"domain_scores_codex":[0.994831,0.001199017,0.002026801,0.0005623738,0.000685717,0.0006951138],"domain_scores_gemma":[0.9933851,0.0006789988,0.004369106,0.0009223003,0.0003434876,0.0003010047],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001081639,0.08645487,0.04520597,0.003641232,0.002473761,0.00591982,0.0002572963,0.000002696403,0.000001864145,0.00008804642,0.0003735077,0.8544993],"study_design_scores_gemma":[0.316391,0.002742738,0.003587533,0.01141596,0.003479901,0.001941363,0.00005310433,0.0001195153,0.0001728241,0.00006716175,0.6590252,0.001003752],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1382896,0.8594902,0.0001163824,0.00003797291,0.0002995724,0.001531921,0.00007526811,0.00001894512,0.0001401793],"genre_scores_gemma":[0.02860264,0.9675856,0.003013929,0.0002656805,0.0001052799,0.0001051216,0.0001754408,0.0001381565,0.000008133872],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8534955,"threshold_uncertainty_score":0.9996675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06276450527285497,"score_gpt":0.3474912599193609,"score_spread":0.2847267546465059,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}